We hope this #4thofJuly inspires the celebration of freedom, relaxation with loved ones, and innovation for our biopharmaceutical partners. From our team to yours, happy #IndependenceDay
Vaniam Group
Advertising Services
Chicago, IL 7,888 followers
People first and purpose-driven | Inc. Best Workplaces | Inc. 5000 Fastest-Growing Private Companies
About us
Vaniam Group is a people-first, purpose-driven, independent network of healthcare and scientific communications agencies committed to helping our clients and our people realize their full potential. Founded in 2007 as a 100% virtual-by-design organization, Vaniam Group is certified Evergreen and a WBENC-Certified Women’s Business Enterprise (WBE). Vaniam Group companies include Bio Linx, Bio Connections, Nexus, Nexus Science, Team 9, Team 9 Science, Second City Insights, Second City Science, CurioScience, Bio Ascend, and Women Leaders in Oncology. Vaniam Group aspires to elevate the way our people and our clients think, work, and communicate within the oncology and hematology therapeutic marketplace. We partner with biotech and pharmaceutical clients’ commercial, medical, and clinical teams to create and communicate a differentiated value proposition at the brand, franchise, and corporate level. By identifying and engaging the right external experts, our clients’ initiatives yield deep insights that in turn inform effective strategies and impactful communication of clinical science. Our virtual-by-design model not only allows us to hire the best talent regardless of geography but inspires us to redefine and unlock the possibilities of the 21st century workplace. To learn more, please contact us at hello@vaniamgroup.com or 773-260-0267.
- Website
-
http://vaniamgroup.com
External link for Vaniam Group
- Industry
- Advertising Services
- Company size
- 201-500 employees
- Headquarters
- Chicago, IL
- Type
- Privately Held
- Founded
- 2007
- Specialties
- Medical Communications, Publication Management, Oncology and Hematology, and Consulting
Locations
-
Primary
Get directions
Chicago, IL 60610, US
Employees at Vaniam Group
Updates
-
At Vaniam Group, we proudly stand with the LGBTQ+ community. This #PrideMonth we celebrated love, diversity, and the courage to be yourself.
-
-
Today, Vaniam Group honors #Juneteenth as we celebrate #FreedomDay for all Americans.
-
-
Vaniam Group and Women Leaders in Oncology participated in #NationalCancerSurvivorMonth at the 31st Annual Cancer Survivors’ Celebration Walk & 5K in Chicago’s Grant Park. Together, we supported patients, their families, and their efforts to transform the future of cancer care for all. #LurieCelebrates #ASCO2024 #WLO
-
Bio Ascend, a Vaniam Group Company, recently held the second class of the Next Wave Forum for Young Investigators™ in #ThoracicOncology. This professional development program will provide year-long mentorship to 18 early-career clinical investigators, guided by co-chairs Julie Brahmer, MD, and Suresh S. Ramalingam, MD, as well as international thought leaders. See the full press release here: https://loom.ly/gmtBCDg #NextWaveAcademy #ProfessionalDevelopment #OncologyAdvancements
-
Our team is excited to be on-site at the #EHA2024 Congress in Madrid, Spain! Connect with us by emailing partnership@vaniamgroup.com to explore how we can accelerate your hematological pipeline.
-
-
Congratulations to Drs Leou Ismael Banla and Erica Pimenta, recipients of Conquer Cancer®, the ASCO Foundation’s 2024 Young Investigator Awards sponsored by Vaniam Group™ and Women Leaders in Oncology®. We are inspired by our annual commitment toward a more equitable future in oncology research. We are proud to honor these exceptional physician scientists! https://lnkd.in/gG48Zi8D
-
Vaniam Group proudly presents abstract #11025, Improving Clinical Trial Performance Using Adult-Learning Methods, at #ASCO2024! #vaniamgroup https://lnkd.in/g8TcmWHS
Vaniam Group™ Presents Data on Improving Clinical Trial Performance at the 2024 ASCO Annual Meeting
prnewswire.com
-
Vaniam Group is officially onsite for #ASCO2024! Join us at Booth 29157 to make meaningful connections as we work toward the future of oncology treatment together.
-
-
Our team is looking forward to connecting with you in person in Chicago this week as we continue #AnticipatingASCO2024.
-